Skip to search.
 TSX Up 0.44% TSX Ventures Up 0.66%

Sanofi (SNY)

-NYSE
49.79 Up 0.26(0.53%) 11:21AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:49.53
Open:49.69
Bid:49.68 x 500
Ask:49.69 x 300
1y Target Est:56.60
Beta:0.96
Next Earnings Date:N/A
Day's Range:49.40 - 49.98
52wk Range:43.57 - 57.42
Volume:659,466
Avg Vol (3m):1,654,940
Market Cap:130.20B
P/E (ttm):27.26
EPS (ttm):1.83
Div & Yield:1.61 (3.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNYUp 0.53%130.20B
GSKUp 1.21%101.80B
MRKUp 1.26%162.87B
PFEUp 0.89%208.31B

Key Statistics

Forward P/E (1 yr):15.52
P/S (ttm):3.30
Ex-Dividend Date:06-May-15

Analysts

Annual EPS Est (Dec-15) :3.16
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):2.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback